These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9126880)

  • 1. Thromboxane A2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors.
    Umemura K; Nakashima M; Saruta T
    Life Sci; 1997; 60(18):1583-8. PubMed ID: 9126880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of a thromboxane-synthetase inhibitor in patients with chronic persistent coughing and no airwayhyperresponsiveness].
    Nishi K; Mizuguchi M; Tachibana H; Watanabe K; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Sep; 35(9):927-33. PubMed ID: 9396248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of thromboxane A(2) in the cough response in guinea-pigs: antitussive effect of ozagrel.
    Shinagawa K; Kojima M; Ichikawa K; Hiratochi M; Aoyagi S; Akahane M
    Br J Pharmacol; 2000 Sep; 131(2):266-70. PubMed ID: 10991919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic persistent coughing successfully treated with ozagrel].
    Nishi K; Mizuguchi M; Tachibana H; Ooka T; Fujimura M; Matsuda T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):350-4. PubMed ID: 8778479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thromboxane A2 synthetase inhibitor in asthma therapy].
    Machida K; Takagi K; Horiba M
    Nihon Rinsho; 1996 Nov; 54(11):3034-9. PubMed ID: 8950950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 1-[3-(4-benzhydryl-1-piperazinyl)propyl]-3- (1H-imidazol-1-ylmethyl)-1H-indole-6-carboxylic acid with thromboxane A2 synthetase inhibitory and H1-blocking activities on anaphylactic bronchospasm.
    Nakamura S; Shirahase H; Kanda M; Wada K; Kamiya S; Matsui H; Kurahashi K
    Arzneimittelforschung; 1996 Nov; 46(11):1067-71. PubMed ID: 8955866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of prophylactic administration of TXA2 synthetase inhibitor, ozagrel hydrochloride, for preeclampsia.
    Seki H; Kuromaki K; Takeda S; Kinoshita K; Satoh K
    Hypertens Pregnancy; 1999; 18(2):157-64. PubMed ID: 10476617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of branch retinal arterial occlusion with sodium ozagrel, a thromboxane A2 synthetase inhibitor.
    Kato H; Emura S; Takeuchi N; Enoki M; Oogushi K; Takashima T; Ohmori K; Saito I
    J Int Med Res; 1997; 25(2):108-11. PubMed ID: 9100166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Research and development of ozagrel, a highly selective inhibitor of TXA2 synthase].
    Nakazawa M; Iizuka K; Ujiie A; Hiraku S; Ohki S
    Yakugaku Zasshi; 1994 Dec; 114(12):911-33. PubMed ID: 7869235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane antagonism and cough induced by angiotensin-converting-enzyme inhibitor.
    Malini PL; Strocchi E; Zanardi M; Milani M; Ambrosioni E
    Lancet; 1997 Jul; 350(9070):15-8. PubMed ID: 9217714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute and chronic effects of thromboxane A2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats.
    Uriu K; Kaizu K; Hashimoto O; Komine N; Etoh S
    Kidney Int; 1994 Mar; 45(3):794-802. PubMed ID: 8196281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The possibility of clinical application of the thromboxane A2 synthase inhibitor, ozagrel, for the treatment and prevention of preeclampsia: a preliminary report.
    Seki H; Kuromaki K; Takeda S; Kinoshita K; Satoh K
    J Obstet Gynaecol (Tokyo 1995); 1995 Aug; 21(4):357-65. PubMed ID: 8775905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ozagrel on locomotor and motor coordination after transient cerebral ischemia in experimental animal models.
    Ichikawa K; Tazawa S; Hamano S; Kojima M; Hiraku S
    Pharmacology; 1999 Nov; 59(5):257-65. PubMed ID: 10529658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a selective thromboxane A2 synthetase inhibitor on the systemic changes induced by circulating pancreatic phospholipase A2.
    Motoyoshi M; Sugiyama M; Atomi Y; Kimura W; Nagawa H
    J Gastroenterol; 2006 Nov; 41(11):1094-8. PubMed ID: 17160520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.
    Terashita Z; Imura Y; Kawamura M; Kato K; Nishikawa K
    Thromb Res; 1995 Mar; 77(5):411-21. PubMed ID: 7778056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cysteinyl-leukotriene receptor antagonist, thromboxane A2 receptor antagonist, and thromboxane A2 synthetase inhibitor on antigen-induced bronchoconstriction in patients with asthma.
    Obase Y; Shimoda T; Matsuo N; Matsuse H; Asai S; Kohno S
    Chest; 1998 Oct; 114(4):1028-32. PubMed ID: 9792572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane A2 synthetase inhibitor failed to ameliorate the arterial narrowing during the chronic phase of cerebral vasospasm.
    Toshima Y; Satoh S; Ikegaki I; Asano T; Suzuki Y; Shibuya M
    Life Sci; 1997; 61(14):1371-7. PubMed ID: 9335226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary administration of a thromboxane A2 synthase inhibitor relieves acetylcholine-induced coronary spasm.
    Sueda S; Kohno H; Inoue K; Fukuda H; Suzuki J; Watanabe K; Ochi N; Kawada H; Uraoka T
    Circ J; 2002 Sep; 66(9):826-30. PubMed ID: 12224820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P.
    Tomaki M; Ichinose M; Miura M; Hirayama Y; Kageyama N; Yamauchi H; Shirato K
    Thorax; 1996 Feb; 51(2):199-201. PubMed ID: 8711657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of thromboxane A2 (TXA2) in the early stages of oleic acid-induced lung injury and the preventive effect of ozagrel, a TXA2 synthase inhibitor, in guinea-pigs.
    Ishitsuka Y; Moriuchi H; Hatamoto K; Yang C; Takase J; Golbidi S; Irikura M; Irie T
    J Pharm Pharmacol; 2004 Apr; 56(4):513-20. PubMed ID: 15099446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.